Summary
Infiltrating transitional cell carcinomas of the urinary bladder were induced by ingestion of 0.188% N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide (FANFT) in 145 female Wistar rats. After 8 months of carcinogen exposure, the animals were divided into different treatment groups. They received cyclophosphamide intraperitoneally as a single injection or BCG either once intralesionally or weekly subcutaneously or a combination of cyclophosphamide followed by subcutaneous BCG. The treatment effect was determined by body weight measurements and bladder tumour weight after 12 months. Compared with a control group statistically significant differences of bladder tumour weights were found after treatment with BCG alone or in combination with cyclophosphamide. Intralesional BCG resulted in an insignificant increase of tumour weights.
Similar content being viewed by others
References
Adolphs, H.-D., Thiele, J., Kiel, H., Steffens, L.: Induction of transitional cell carcinoma of the urinary bladder in rats by feeding N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide. Histological and ultrastructural findings. Urological Research 6, 19 (1978)
Amiel, J. L., Berardet, M.: Factor time for active immunotherapy after cytoreductive chemotherapy. European Journal of Cancer 10, 89 (1974)
Baldwin, R. W., Price, M. R., Robins, R. A.: Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumourspecific antigen-antibody complexes. Nature (New Biol.) 238, 185 (1972)
Baldwin R. W., Pimm, M. V.: BCG immunotherapy of pulmonary growths from intravenously t transferred rat tumour cells. British Journal of Cancer 27, 48 (1973)
Bansal, S. C., Sjögren, H. O.: Effects of BCG on various facets of the immune response against polyoma tumors in rats. International Journal of Cancer 11, 162 (1973)
Bast, R. C., Zbar, B., Borsos, T., Rapp, H. J.: BCG and cancer (1). New England Journal of Medicine 290, 1413 (1974)
Bast, R. C., Zbar, B., Borsos, T., Rapp, H. J.: BCG and cancer (1). New England Journal of Medicine 290, 1458 (1974)
Bekierkunst, A.: Immunotherapy of cancer with nonliving mycobacteria and cord factor (trehalose-6,6′-dimycolate) in aqueous medium. Journal of the National Cancer Institute 57, 963 (1976)
Bogden, A. E., Esber, H. J., Taylor, D. J., Gray, J. H.: Comparative study on the effects of surgery, chemotherapy, and immunotherapy, alone and in combination, on metastases of the 13762 mammary adenocarcinoma. Cancer Research 34, 1627 (1974)
Buskirk, H. H., Crim, J. A., Petering, H. G., Merritt, K., Johnson, A. G.: Effect of uracil mustard and several antitumor drugs on the primary antibody response in rats and mice. Journal of the National Cancer Institute 34, 747 (1965)
Chaussoux, D., Salomon, J.-C.: Therapeutic effect of intratumoral injection of BCG and other substances in rats and mice. International Journal of Cancer 16, 515 (1975)
Currie G. A., Bagshawe, K. D.: Active immunotherapy with corynebacterium parvum and chemotherapy in murine fibrosarcomas. British Medical Journal 1, 541 (1970)
Daly, J. J., Prout Jr., G. R., Ahl, C. A.: Demonstration of specific antigen in N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide induced rat bladder tumor. Journal of Urology 109, 253 (1973)
DeKernion, J. B., Soloway, M. S., Persky, L.: Chemotherapy of experimental transitional-cell carcinoma. Urology 4, 63 (1974)
Ertürk, E., Price, J. M., Morris, J. E., Cohen, S. M., Leith, R. S., von Esch, A. M., Crovetti, A. J.: The production of carcinoma of the urinary bladder in rats by feeding N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide. Cancer Research 27, 1998 (1967)
Ertürk, E., Cohen, S. M., Price, J. M., Bryan, G. T.: Pathogenesis, histology, and transplantability of urinary bladder carcinomas induced in albino rats by oral administration of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide. Cancer Research 29, 228 (1969)
Gheorghiu, M., Chambon, L.: Preservation of fresh BCG-scarification vaccine at 4,-25, and-70°C. Cancer Immunology and Immunotherapy 1, 11 (1976)
Gray, G. R., Ribi, E., Granger, D., Parker, R., Azuma, I., Yamamoto, K.: Brief communication: Immunotherapy of cancer: tumor suppression and regression by cell walls of mycobacterium phlei attached to oil problets. Journal of the National Cancer Institute 55, 727 (1975)
Gutterman, J., Mavlight, G., McBride, C. E., Frei III, E., Hersh E. M.: BCG stimulation of immune responsiveness in patients with malignant melanoma. Cancer 32, 321 (1973)
Haines, R. F., Johnson, A. E., Petering, H. G.: Variable influences of antitumor drugs and progestational agents on immune responses in rodents. Federation Proceedings 26, 934 (1967)
Halle-Pannenko, O., Bouret, C., Kamel, M.: Comparison of various BCG preparations in the EORTC-ICIG experimental screening for systemic immunity adjuvants applicable to cancer immunotherapy. Cancer Immunology and Immunotherapy 1, 17 (1976)
Hanna Jr., M. G., Peters, L. C., Gutterman, J. U., Hersh, E. M.: Evaluation of BCG administered by scarification for immunotherapy of metastatic hepatocarcinoma in the guinea pig. Journal of the National Cancer Institute 56, 1013 (1976)
Harmel Jr., P. R., Zbar, B., Rapp, H. J.: Brief communication: Suppression and regression of a transplanted tumor in the guinea pig colon mediated by mycobacterium bovis, strain BCG. Journal of the National Cancer Institute 54, 515 (1975)
Jacobs, J. B., Arai, M., Cohen, S. M., Friedell, G. H.: A long-term study of reversible and progressive urinary bladder cancer lesions in rats fed N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide. Cancer Research 37, 2817 (1977)
Khalil, A., Bourut, C., Halle-Pannenko, O., Mathé, G., Rappaport, H.: Histologic reactions of the thymus, spleen, liver and lymph nodes to intravenous and subcutaneous BCG injections. Biomedicine 22, 122 (1975)
Kiel, H., Adolphs, H.-D., Thiele, J., Steffens, L.: Biological behavior or N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide induced carcinoma of the transitional epithelium in the rat. Zeitschrift für Krebsforschung 91, 267 (1978)
Koss, L. G.: Tumors of the urinary bladder. Atlas of tumor pathology, Fasc. 11. Washing D. C.: Armed Forces Institute of Pathology, 1975
MacKanness, G. B., Auclair, D. J., Lagrange, P. H.: Immunopotentiation with BCG. I. Immune response to different strains and preparations. Journal of the National Cancer Institute 51, 1655 (1973)
Mathé, G., Amiel, J. L., Schwarzenberg, L., Schneider, M., Cattan, A., Schlumberger, J. R., Hayat, M., de Vassal, F.: Active immunotherapy for acute lymphoblastic leukaemia. Lancet 1, 697 (1969)
Mathé, G., Halle-Pannenko, O., Bouret, C.: Immune manipulation by BCG administered before or after cyclophosphamide for chemoimmunotherapy of L 12 10 leukaemia. European Journal of Cancer 10, 661 (1974)
Moertel, C. G., Ritts, jr., R. E., Schutt, A. J., Hahn, R. G.: Clinical studies of methanol extraction residue fraction of bacillus Calmette-Guérin as an immunostimulant in patients with advanced cancer. Cancer Research 35, 3075 (1975)
Mostofi, F. K., Sobin, L. H., Torloni, H.: Histological typing of urinary bladder tumors. In: International histological classification of tumors. 10, WHO, Geneva (1973)
Pai, S. H., Amaral, L., Werthamer, S., Zak, F. G.: Ultrastructure and reversibility of bladder carcinoma of rats produced by feeding of N-[4-(5-nitro-2-furyl)-2-thiazozyl] formamide. Investigative Urology 11, 125 (1973)
Pearson, J. W., Perk, K., Chirigos, M. A., Pryor, J. W., Fuhrman, F. S.: Histological and combined chemoimmunostimulation therapy studies against a murine leukemia. International Journal of Cancer 16, 142 (1975)
Purnell, D. M., Bartlett, G. L., Kreider, J. W., Biro, T. G.: Corynebacterium parvum and cyclophosphamide as combination treatment for a murine mammary adenocarcinoma. Cancer Research 37, 1137 (1977)
Santos, G. W.: Immunosuppressive drugs I. Federation Proceedings 26, 907 (1967)
Sher, N. A., Pearson, J. W., Chaparas, S. D., Chirigos, M. A.: Effect of three strains of BCG against a murine leukemia after drug therapy. Journal of the National Cancer Institute 51, 2001 (1973)
Sher, N. A., Chaparas, S. D., Pearson, J. W., Chirigos, M. A.: Virulence of six strains of mycobacterium bovis (BCG) in mice. Infection and Immunity 8, 736 (1973)
Sjögren, H. O., Hellström, I., Bansal, S. C., Hellström, K. E.: Suggestive evidence that the “blocking antibodies” of tumor-bearing individuals may be antigen-antibody complexes. Proceedings of the National Academy of Science 68, 1372 (1971)
Smith, H. G., Bast jr., R. C., Zbar, B., Rapp, H. J.: Eradication of microscopic lymph node metastases after injection of living BCG adjacent ot the primary tumor. Journal of the National Cancer Institute 55, 1345 (1975)
Soloway, M. S.: Single and combination chemotherapy for primary murine bladder cancer. Cancer 36, 333 (1975)
Sparks, F. C., Breeding, J. H.: Tumor regression and enhancement resulting from immunotherapy with bacillus Calmette-Guérin and neuraminidase. Cancer Research 34, 3262 (1974)
Sparks, F. C., Albert, N. E., Breeding, J. H.: Effect of isonicotinic acid hydrazide on the intratumor injection of BCG. Journal of the National Cancer Institute 58, 367 (1977)
Tanaka, T., Sasaki, N.: Effect of immunotherapy, chemotherapy, and surgery on tumor immunity in mice. Gann 65, 395 (1974)
Tiltman, A. J., Friedell, G. H.: The histogenesis of experimental bladder cancer. Investigative Urology 9, 218 (1971)
Tokunaga, T., Yamamoto, S., Nakamura, R. M., Kataoka, T.: Immunotherapeutic and immunoprophylatic effects of BCG on 3-methylcholanthrene-induced autochthonous tumors in swiss mice. Journal of the National Cancer Institute 53, 459 (1974)
Wang, C. Y., Hayashida, S., Pamukcu, A. M., Bryan, G. T.: Enhancing effect of allopurinol on the induction of bladder cancer in rats by N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide. Cancer Research 36, 1551 (1976)
Yalciner, S., Friedell, G. H.: Cilia in the epithelium of the urinary bladder during experimental carcinogenesis. Journal of the National Cancer Institute 51, 501 (1973)
Youn, J. K., le Francois, D., Santillana, M., Hue, G., Barski, G.: Effect of BCG treatment on the evaluation of cell-mediated immunity in mice bearing transplantable syngeneic tumors. European Journal of Cancer 13, 177 (1977)
Zbar, B., Ribi, E., Meyer, T., Azuma, I., Rapp, H. J.: Immunotherapy of cancer: regression of established intradermal tumors after intralesional injection of mycobacterial cell walls attached to oil droplets. Journal of the National Cancer Institute 52, 1571 (1974)
Zbar, B., Rapp, H. J.: Immunotherapy of guinea pig cancer with BCG. Cancer 54, 1532 (1974)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Adolphs, H.D., Thiele, J. & Kiel, H. Effect of intralesional and systemic BCG-application or a combined cyclophosphamide/BCG treatment on experimental bladder cancer. Urol. Res. 7, 71–78 (1979). https://doi.org/10.1007/BF00254684
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00254684